Mayo Clinic proceedings
-
Mayo Clinic proceedings · Feb 2025
Multicenter StudyAcademic Promotions in Medicine: Characterizing Differences in Curriculum Vitae Across Race and Sex.
Evaluate quantitative and qualitative differences by sex and race/ethnic identities in curriculum vitae (CV) of faculty candidates for promotion. ⋯ The participants' CV demonstrated notable differences associated with the candidate's race/ethnicity and sex.
-
Mayo Clinic proceedings · Dec 2024
Multicenter StudyPatient Perceptions of East and Southeast Asian Physicians Amidst Anti-Asian Rhetoric During the COVID-19 Pandemic.
To examine the effects of anti-Asian rhetoric on how patients perceive East/Southeast Asian physicians. This study examines changes in patient satisfaction scores of East/Southeast Asian physicians in a multisite health system following the onset of the COVID-19 pandemic. ⋯ These findings contribute to the growing literature on the experience of Asian health care workers in the United States and highlight the need for further investigation into the experiences of physicians of color during the volatility of the pandemic.
-
Mayo Clinic proceedings · Jul 2024
Multicenter Study Comparative StudyCoaguChek and Coag-Sense PT2 Meter Point of Care INR Device Validation.
To standardize international normalized ratio (INR) measurements and improve data integrity by enabling electronic result transmission for warfarin monitoring, two point-of-care (POC) devices were evaluated against an internal plasma INR reference method. ⋯ Compared with a plasma referent, INR values obtained from the CoaguChek devices exhibited less systematic bias compared with Coag-Sense measures. This translates to a greater percentage of concordant management decisions between POC and laboratory INR methods.
-
Mayo Clinic proceedings · Jun 2024
Multicenter StudyClinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry.
To explore the association between metabolic status, body mass index (BMI), and natural history of patients with atrial fibrillation (AF). ⋯ Increasing BMI was associated with poor metabolic status and with more intensive treatment. Prognosis was heterogeneous between BMI groups, with metabolically unhealthy patients showing higher risk of adverse events.
-
Mayo Clinic proceedings · Jun 2024
Multicenter StudyEfficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study.
To investigate whether hypotensive patients diagnosed with heart failure and reduced ejection fraction (HFrEF) might benefit from angiotensin receptor-neprilysin inhibitors (ARNis) in real-world practice because patients with baseline systolic blood pressure (SBP) of less than 100 mm Hg have been excluded from landmark trials. ⋯ Patients with HFrEF and hypotension may still benefit from ARNi treatment. Patients with hypotensive HFrEF should not be routinely excluded from ARNi use in a real-world setting.